What do you think is going on here? The main report is that the death counts lag behind infection rates. But the pandemic (I like the term “patchwork pandemic”) has been raging through Florida, Arizona and Texas for quite some time now. Are we looking at a less lethal SARS CoV-2? It would appear so.…
It’s an understandable concern based on past experiences with other viral infections, such as influenza and measles, where children are known to be significant transmitters. However, according to several recent publications, infected children are less significant spreaders of COVID-19 and their own source of infection may more likey be symptomatic or pre-symptomatic adults. Adults who…
BRCA1/2 gene mutations, not included in direct-to-consumer genetic testing, are associated with higher rates of ovarian cancer (17-44%) and breast cancer (69-72%). A new study argues that routine testing for these gene vulnerabilities could prevent up to an estimated 2,666 cases of breast cancer per million women, and up to 449 ovarian cancer cases per…
COVID-19 outcome disparities are rapidly becoming apparent for people with obesity and multiple black, Asian, and minority ethnic (BAME) groups.
We’ve known clinically that PCOS doesn’t always present as, well, PCOS. There is a far broader collection of phenotypes for PCOS than has been adequately documented. Thus, I was pleased to see this recent paper looking at PCOS subtypes and genetic associations.
In reference to the article: Quercetin: New Hype for COVID-19? We appreciate MPT’s reference to our phases paper and quote of Sam Yanuck, as well as their mention of the East Virginia Med School work. But there are more human clinical trials than the pharma PhDs suggest, which demonstrates bioavailability and efficacy. As…
Two important legal battles reached decision points on settlements and damages recently – one against Johnson & Johnson’s talc products and the other against Monsanto’s Roundup, both for causing cancers. If you don’t already avoid these products, we recommend that you do. Johnson & Johnson is ordered to pay $2.1 billion to women who claim…
Protective antibodies against COVID-19 may only last a short time after infection, new evidence shows. However, it doesn’t mean that scientists have definitively answered the question about lasting immunity for this particular virus. The current thinking is that even low levels of powerful neutralizing antibodies may still be protective – after all, the immune system…
COVID19 is upon us. Months earlier, we scheduled James Maskell to discuss his recent book: The Community Cure. Amazingly, his message today is all the more urgent. James argues for the group visit model, was an early adopter and proponent of group visits (in fact, we discuss the pre-publication Cleveland Clinic group visit research findings, which are astonishingly good; even better than the first JAMA publication comparing functional medicine one-on-one with family medicine.) Now, with COVID19 and self-isolation, the virtual visit and the virtual group visit (where James saw FxMed eventually going) is upon us. And specifically, his vision is that this model works in insurance- and even Medicare. James’ message – the promise of functional medicine – is timely, inspiring and essential. ~DrKF
Shedding Light on Our Own Implicit Biases – A Useful Harvard Tool
